Fecal microbiota transplantation: past, present and future
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Fecal microbiota transplantation (FMT) re-establishes a balanced intestinal flora with resultant cure of recurrent Clostridium difficile infection (RCDI). FMT has also been used to treat other gastrointestinal (GI) diseases including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and chronic constipation and a variety of non-GI disorders. The purpose of this review is to discuss the intestinal microbiota and FMT treatment of GI and non-GI diseases. RECENT FINDINGS: It is known that an imbalanced intestinal microbiota predisposes to CDI, IBD and IBS. The complex role of intestinal microbiota to maintain health, however, is a newer concept that is being increasingly studied. The microbiome plays an important role in cellular immunity and energy metabolism and has been implicated in the pathogenesis of non-GI autoimmune diseases, chronic fatigue syndrome, obesity and even some neuropsychiatric disorders. SUMMARY: FMT is a highly effective cure for RCDI, but increased knowledge of the intestinal microbiota in health maintenance, as well as controlled trials of FMT in a wide range of disorders are needed before FMT can be accepted and applied clinically.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several case reports and animal models have also revealed the probable therapeutic effects of FMT in patients with severe multiple sclerosis, 41 autism, 42 multidrug-resistant organisms (MDRO) infections, 43 and multiple organ dysfunction in critical patients.44”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [42]
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Furthermore, the obese (ob/ob) phenotype has been shown to be transmissible and is adopted in germ- free mice, infused with intestinal microbiota from conventionally raised, genetically obese mice [58].”
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“conventionally raised mice are introduced into germ-free mice [59].”
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
Self-citationGough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
(1958) · PubMed · Cited by 978
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Research works printed but not linked: 12
- Borody, 1989, ust, 150, 604
- Anathaswamy, 2011, New Scientist, 2796, 8
- Eiseman, 1958, Surgery, 44, 854
- Persky, 2000, Am J Gastroenterol, 95, 3283
- Cohen, 2010, Infect Control and Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
- Huebner, 2006, Gastroenterol Hepatol, 2, 203
- Lund-Tonnesen, 1998, Tidsskr Nor Laegeforen, 118, 1027
- Silverman, 2010, Clin Gastroenterol Hepatol, 8, 471, 10.1016/j.cgh.2010.01.007 · DOI · Paper page
- Andrews, 1995, Gastroenterology, 108, A563
- Borody, 2011, Am J Gastroenterol, 106, S352
- Borody, 2011, Am J Gastroenterol, 106, S352
- Borody, 2011, Am J Gastroenterol, 106, S352
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
“difficile, where a single dose generally leads to recovery within a few days [60].”
BackgroundCurrent Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122
“difficile infection (CDI), with a cure rate exceeding 90% to 95% worldwide.(95) Patients with CDI usually will remain on antimicrobials until 2 to 3 days before FMT.”
BackgroundAntimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 780
Luczynski, P., McVey Neufeld, K.-A., Oriach, C. S., Clarke, G., Dinan, T. G., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw020 · Cited by 632
“…inoculated from animal models of disease (Turnbaugh et al., 2006, 2009b; Bercik et al., 2011a; Borody and Khoruts, 2012; Cryan and Dinan, 2012; Aroniadis and Brandt, 2013; Ridaura et al., 2013; Suez et al., 2014; Thaiss et al., 2014; Leone et al., 2015), thus enabling the study of the…”
Background
Metadata
- Authors
- Aroniadis, O. C., & Brandt, L. J.
- Affiliations
- Montefiore Medical Center (US)
- Corresponding author
- Aroniadis, Olga C.
- Venue
- Current Opinion in Gastroenterology
- Published
- 2013-01
- Volume
- 29
- Issue
- 1
- Pages
- 79-84
- ISSN
- 0267-1379 (ISSN-L)
- OpenAlex
- W2025589766
- Cited by
- 336
- References
- 51
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 15 · 2023: 9 · 2022: 33 · 2021: 25 · 2020: 36 · 2019: 27 · 2018: 27 · 2017: 22 · 2016: 29 · 2015: 27 · 2014: 38 · 2013: 29
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, gut microbiota, Clostridium difficile infection, inflammatory bowel disease, irritable bowel syndrome, chronic constipation, autoimmune disease, obesity, chronic fatigue syndrome, neuropsychiatric disorders, energy metabolism, cell-mediated immunity
- MeSH terms
- Autistic Disorder, Autoimmune Diseases, Constipation, Enterocolitis, Pseudomembranous, Feces, Humans, Nervous System Diseases, Obesity, Recurrence, Inflammatory Bowel Diseases, Fatigue Syndrome, Chronic, Clostridioides difficile, Irritable Bowel Syndrome, Donor Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.